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Discrepancies between blood group genotype and RBC phenotype
are important to recognize when implementing DNA-based blood
grouping techniques. This report describes two such cases
involving the ABO blood group in the Korean population.
Propositus #1 was a 22-year-old healthy man undergoing
pretransfusion testing for minor surgery. Propositus #2 was a 23-
year-old male blood donor. RBCs from both propositi were
determined to be group AB and demonstrated unusual
agglutination patterns on forward typing, which were inconsistent
with their ABO genotype determined by allele-specific (AS) PCR.
RBCs from propositus #1 demonstrated mixed field agglutination
with both anti-A and -B, while RBCs from propositus #2
demonstrated mixed field only with anti-A reagents. Both had B/O
genotypes by AS-PCR. Cloning and sequencing of ABO exons 6 and
7 revealed three alleles in both propositi: propositus #1:
A102/B101/O04; propositus #2:A102/B101/O01. A panel of nine
short-tandem repeat (STR) loci was tested on DNA extracted from
blood, buccal mucosal cells, and hair from the propositi and on
DNA isolated from their parents’ blood. In all tissues tested from
propositus #1, three loci demonstrated a double paternal and a
single maternal DNA contribution, indicating that he was a chimera
or a mosaic; in those from propositus # 2, one STR locus
demonstrated a double paternal DNA contribution, indicating that
he was a tetragametic chimera. Chimerism and mosaicism are
uncommon but important causes of ABO genotype and phenotype
discrepancies. The evaluation of patients and donors with unusual
or unexpected serology in pretransfusion testing and consensus
ABO alleles may include the evaluation of STR loci to detect these
phenomena. Immunohematology 2006;22:183–187.
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Chimeric individuals result from the fusion of two
or more zygotes. They differ from mosaic individuals
whose cells carry different complements of DNA
derived from a single zygote.1,2 Chimeric individuals
generally are healthy, but often feature differentially
pigmented patches of skin or eyes of different colors.
Both of these genetic variants can give rise to ABO
discrepancies if RBCs with different ABO groups are
produced or if a naturally occurring ABO antibody is
unexpectedly absent, as revealed on reverse typing.
Resolving an ABO discrepancy caused by weak or
unusual agglutination on forward typing can require an
investigation into the patient’s transfusion history and
clinical diagnosis and potentially a molecular
evaluation of the ABO gene. With the identification of
the ABO alleles byYamamoto et al.,3 it became possible
to determine a blood donor’s or recipient’s ABO blood
group at the DNA level. The molecular bases of
numerous ABO subtypes in several populations have
been elucidated.4 In Korea, the overall frequency of A
and B subtypes among blood donors was reported to
be 0.1 percent with cis-AB01 among the most
commonly identified subtype alleles.5 This allele can
produce various phenotypes including A1B3,AintB3,A2B3,
and A2B and its presence should be considered when
evaluating an ABO discrepancy, especially in Korean
and Japanese populations, where this allele is most
commonly found.5 A detailed description of the cis-AB
phenotype can be found in reference 6. On the basis
of common ABO gene polymorphisms in the Korean
population, allele-specific (AS) PCR primers to detect
A, B, O, and cis-AB01 alleles were designed and used in
resolving ABO discrepancies.7 ABO genotyping is also
used as an initial means of resolving disputed paternity
claims, which are not infrequent because of the
relatively high prevalence of the cis-AB blood group in
Korea.5 We have recently discovered two instances
where the results of AS-PCR have not been in accord
with the patients’ RBC phenotypes obtained by
serologic methods. Both of these cases were shown by
further molecular testing to be chimeras or mosaics.
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Materials and Methods
Blood group serologic tests
Forward typing was carried out by the manual tube
method using murine monoclonal anti-A, anti-B, anti-H,
and anti-AB (Biotest AG, Dreieich, Germany) according
to standard protocols. Reverse typing was also
performed by tube methods using A1 and B RBCs
(Diamed,Cressier sur Morat, Switzerland). The forward
and reverse typings were repeated using gel cards
containing monoclonal anti-A and anti-B in cases where
ABO subtypes were suspected (Diamed).
Preparation of DNA
EDTA-whole blood, buccal mucosal cells, and hair
follicles were obtained from the propositi. Genomic
DNA extraction was performed using the Wizard
Genomic DNA purification kit (Promega Corporation,
Madison, WI) on EDTA-blood and the QIAamp DNA
micro kit (Qiagen,Hilden,Germany) on buccal mucosal
cells and hair follicles. Informed consent was obtained
from the study participants before their samples were
drawn.
Sequence based typing for HLA-A, -B, and -DR
DNA sequencing-based typing (SBT) for HLA class I
and II alleles was performed with commercially
available AlleleSEQR HLA -A, -B,and -DRB1 SBT reagents
(Atria Genetics, San Francisco, CA) according to
manufacturer’s instructions. The sequence results were
analyzed with Assign-SBT (Conexio Genomics,
Applecross,Western Australia,Australia) software.
Short-tandem repeat analysis
We studied short tandem repeats (STR) on
autosomal chromosomes using commercially available
kits for the following loci: vWA,FGA,D3S1358,D5S818,
D7S820, D8S1179, D13S317, D18S51, and D21S11
(AmpFlSTR Profiler Plus PCR Amplification Kit, ABI,
Perkin Elmer/Applied Biosystems, Foster City, CA).
Analysis was performed using the ABI PRISM 310
Genetic Analyzer (Perkin Elmer/Applied Biosystems).
Karyotyping
Peripheral blood specimens from both propositi
and their parents were studied. Approximately 0.5 mL
of whole blood was cultured in 10 mL of Roswell Park
Memorial Institute (RPMI) 1640 (Gibco, Invitrogen
Corporation, Grand Island, NY) with 10% fetal bovine
serum and 50 U of penicillin-streptomycin for 72
hours. The cultures were then stimulated with PHA
and 20 metaphase cells stained by G-staining methods
were karyotyped. The karyotypes were described
according to the International System for Cytogenetic
Nomenclature 2005.
Molecular analysis of ABO gene
1.Allele-specific PCR
AS-PCR at nucleotides (nt) 261 (exon 6) and at nt
526 and 803 (exon 7) of the ABO gene to discriminate
between the A, B, O, and cis-AB01 alleles was
performed using previously described methods.7 The
primers were designed using a modified amplification
refractory mutation system. In this technique, the
primers’ penultimate base was mismatched to increase
the specificity of the PCR
PCR was performed in a reaction mixture of 50 µL
with 0.25 µM of each primer pair, 300 ng of genomic
DNA, 0.2 µM (each) dNTP, 1X PCR buffer [10mM Tris-
HCl (pH 8.8), 1.5mM MgCl2, 50 mM KCl, 0.1% TritonX-
100],and 2 U DynaZyme (Finzyme Inc.,Finland). Thirty
cycles of amplification were performed by manual hot-
start PCR in a MJ Research PTC-100 thermocycler (MJ
Research INC., Watertown, MA) after an initial
denaturation at 95°C for 5 minutes. Each cycle
consisted of a denaturation step at 94°C for 30
seconds, an annealing step at 64°C for 30 seconds, and
an extension step at 72°C for 1 minute. An additional
primer extension at 72°C for 10 minutes followed the
last cycle. PCR products were separated at 100v for 40
minutes on 1.8% agarose gel prestained with ethidium
bromide (0.5 µg/mL).
2. Cloning and sequencing of exons 6 and 7
Genomic DNA was extracted from peripheral
WBCs with a DNA isolation kit (SolGent, Daejeon,
Korea). The coding and flanking intronic sequences of
exons 6 and 7 were amplified, cloned, and sequenced.5
For the cloning, PCR products (2080 bp) were directly
inserted into the PCR 2.1–TOPO vector and
transformed into TOP 10 host cells using the TOPO-TA
cloning kit (Invitrogen, Carlsbad, CA). The sequencing
reaction was performed in a 10 µL mixture containing
5X sequencing buffer, 4 µL of BigDye, 200 ng of
purified DNA, 2 µL of primer (1.6 pmoles/µL).
Sequence analysis was performed using SEQUENCHER
(Gene Codes Corp, Ann Arbor, MI) software. Alleles
were named according to the unofficial nomenclature
used in the Blood Group Antigen Gene Mutation
Database.4
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Case Studies and Results
Propositus #1 was a healthy 22-year-old man.
Routine pretransfusion testing prior to minor surgery
revealed an unusual blood group: approximately one
half of his RBCs showed strong (4+) agglutination with
anti-A and anti-B sera on forward typing while the
remaining RBCs were unagglutinated (mixed field
agglutination). His serum did not react with A1 or B
RBCs. Furthermore, his blood group was unusual
because his father was group AB and his mother was
group O (Table 1, Fig. 1). Propositus #2 was a healthy
23-year-old blood donor whose RBCs demonstrated
strong and uncomplicated agglutination on forward
typing with anti-B reagents but mixed field
agglutination with anti-A reagents (Table 1, Fig. 1). His
serum did not react with A1 or B RBCs.
Both propositi were morphologically normal,had no
known twins, and denied ever receiving a blood
transfusion or a stem cell or solid organ transplant.
Samples from these propositi were to detect a cis-AB
allele in propositus #1 and to elucidate the molecular
basis of the mixed field agglutination in propositus #2.
By AS-PCR performed on DNA extracted from peripheral
blood, the ABO genotype of both propositi was B/O.
Cloning and direct sequencing of ABO exons 6 and 7
revealed three alleles in both propositi: propositus #1:
Table 1. Summary of the serologic blood group determinations, sequence-based HLA typing, and karyotypes of both propositi and their parents
Propositus Age, Sex Antigen system Father Mother Propositus
1 22,M ABO phenotype AB O AmfBmf
Genotype (sequencing) A102/B101 O02/O04 A102/B101/O04
AS-PCR (A/B) (O/O) (B/O)
Rh DcEe DCe DCcEe
HLA-A A*3303 A*0201 A*0201
A*3303 A*3303 A*3303
HLA-B B*4403 B*3501 B*3501
B*5801 B*5801 B*4403
HLA-DRB1 DRB1*0701 DRB1*0403 DRB1*0403
DRB1*1302 DRB1*1302 DRB1*0701
Karyotype 46,XY 46,XX 46,XY
2 23,M ABO phenotype A B AmfB
Genotype (sequencing) A102/O01 B101/O01 A102/B101/O01
AS-PCR (A/O) (B/O) (B/O)
Rh DCe DCe DCe
HLA-A A*0201 A*2402 A*0201
A*3303 A*3002 A*3002
HLA-B B*2704 B*0702 B*1401
B*4403 B*1401 B*2704
HLA-DRB1 DRB1*0405 DRB1*0101 DRB1*0405
DRB1*1302 DRB1*0802 DRB1*0802
Karyotype 46,XY 46,XX 46,XY
mf = mixed field agglutination
Fig. 1. In propositus #1 (P1, top), mixed field agglutination was
observed with anti-A and anti-B sera indicating the simultaneous
presence of two distinct RBC populations. This propositus’ A
allele was not detected until exons 6 and 7 were cloned and
sequenced. In propositus #2 (P2, bottom), a mixed field
agglutination pattern was observed with anti-A because of the
presence of A and B RBCs. SSP = sequence-specific primer, SBT
= sequence based typing.
P1
P2
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A102/B101/O04 (likely genotype: A102/O04 plus
B101/O04); propositus #2: A102/B101/O01 (inferred
ABO genotype from serological results:A102/B101 and
B101/O01) (Table 1). The brother and sister of
propositus #1 demonstrated uncomplicated B and A
phenotypes and genotypes, respectively. A panel of nine
STR loci was tested on DNA extracted from blood,
buccal mucosal cells, and hair from both propositi, and
on DNA isolated from blood from their parents. In
propositus #1,three loci demonstrated a double paternal
and a single maternal DNA contribution from all tissue
samples studied (Table 2, Fig. 2). The FGA locus was
uninformative in the propositus as his parents shared an
allele. In propositus #2, one STR locus (D7S820)
demonstrated a double parental DNA contribution,
while other loci were uninformative in that they
revealed either double maternal or paternal DNA
contributions with only a single contribution from the
other parent, or else it was
not possible to determine if
the propositus’ extra allele
was maternal or paternal
owing to shared alleles
between the parents (Table
2, Fig. 2). Both propositi had
normal male (46, XY)
karyotypes. DNA-sequence
based HLA typing revealed




Propositus #1 demonstrated one maternal and two
paternal DNA contributions in all tissues tested. There
are two embryologic explanations for this finding: he
might be a mosaic who arose from one zygote with
three pronuclei instead of the normal two, i.e., the
zygote was formed from one ovum containing a haploid
nucleus fertilized by two haploid sperm nuclei
(dispermy) or one ovum plus one diploid sperm nucleus
(diplospermy). Dispermy is a frequent event (1% of
human conceptions) and results in a triploid zygote.8 As
the zygote divides, some or all daughter cells become
diploid.9 Thus, if one zygote with three pronuclei
survived as an embryo, it would be composed of
different cell populations.9 Equally plausible,however, is
that propositus #1 is a dispermic chimera resulting from
the parthenogenetic division of the ovum and its
subsequent fertilization by two spermatozoon carrying
different paternal DNA—one with a 23,Y chromosome
complement and another spermatozoon with a different
23,Y DNA complement.10 This would explain the
apparent single maternal and double paternal DNA
contribution. Propositus #2 is a tetragametic chimera
because one STR locus clearly demonstrated the
presence of two maternal and two paternal alleles. The
finding of only a single parental HLA type in these
individuals was unexpected but a similar finding has
been previously reported.11 The detection of only one
parental HLA haplotype in this tetragametic chimera
probably relates to the relatively lower sensitivity of HLA
typing methods compared with STR techniques.
In this study, both propositi were initially found to
have ABO genotype and phenotype discrepancies; both
had group A and group B RBCs detectable by serologic
methods, but only demonstrated B and O alleles by AS-
PCR, i.e., an A allele was not initially detected in either
Table 2. STR analysis of both propositi and their parents. Only the informative loci are shown for each
propositus.
DNA Father Mother Propositus Propositus Propositus
Propositus polymorphism (blood) (blood) (blood) (buccal cells) (hair)
1 D8S1179 10,14 12,15 10,12,14 10,12,14 10,12,14
vWA 16,19 15,18 15,16,19 15,16,19 15,16,19
FGA 22,23 17,22 17,22,23 17,22,23 17,22,23
2 D7S820 9,10 8,12 8,9,10,12 8,9,10,12 8,9,10,12
Italicized alleles indicate paternally derived alleles.
Bolded alleles indicate maternally derived alleles.
Underlined alleles indicate those that are shared by mother and father and are uninformative in the propositus.
Fig. 2. STR analysis in the father (F), propositus (P), and mother (M) on
DNA isolated from blood. Fragment size is indicated below each
peak. In propositus #1, two STR loci reveal a double paternal
DNA contribution, while only a single maternal DNA
contribution is detectable. In propositus #2, one STR locus
demonstrated a double maternal and double paternal
contribution thus confirming this propositus as a tetragametic
chimera. Identical STR results were found in the DNA isolated
form buccal swabs and hair cells from both propositi.
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propositus using this technique, probably because of
the relative insensitivity of this test and the small
quantity of DNA containing an A allele present. In fact,
the cis-AB phenotype was initially suspected in
propositus #1. The failure,by AS-PCR, to detect an allele
known to encode the cis-AB phenotype led us to
perform the STR testing and gene sequencing which
revealed the cause of his unusual forward typing. When
propositus #2 was an embryologic explanation for his
genotype and phenotype discrepancy was sought. The
mixed field agglutination pattern of RBCs was thus the
result of the simultaneous presence of separate group A
and group B RBCs in propositus #1 and of separate
group AB and B RBCs in proprositus #2. As these two
cases suggest, chimerism and mosaicism can confound
ABO genotyping such that if blood group genotyping
becomes more commonly used, more cases might be
identified in attempts to explain similar genotype and
phenotype discrepancies.11,12 Our approach to the
evaluation of patients with unusual serology on forward
typing and consensus ABO alleles now includes the
evaluation of STR loci in the propositus and available
relatives to determine if chimerism or mosaicism is
responsible for the unusual ABO phenotype.
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